Potassium Gluconate Market - Forecast(2024 - 2030)

Report Code: HCR 41721 Report Format: PDF + Excel

Potassium Gluconate Market Overview

Potassium Gluconate Market size is estimated to reach $1.3 billion by 2027, growing at a CAGR of 4.1% during the forecast period 2022-2027. Potassium gluconate is the potassium salt of the conjugate base of gluconic acid. Physiologically, gluconic acid is a significant intermediate product of carbohydrate metabolism. Potassium gluconate is a salt of Potassium cation and is categorized as a food supplement by the Food And Drug Administration (FDA). A potassium-sparing diuretic is a medication that boosts diuresis (urination) without the loss of potassium. It is typically a weak diuretic and performs by intruding with the sodium-potassium swap in the distal convoluted tubule of the kidneys or as an antagonist at the aldosterone receptor. Etacrynic acid increases the effect of the activities of cardiac glycosides if it brings about potassium reduction. Transderm-scop medications like scopolamine can interreact with potassium gluconate and the patient needs to inform the physician regarding their usage. The soaring count of patients with low potassium levels requiring the application of potassium gluconate which is a salt of potassium cation is set to drive the Potassium Gluconate Market owing to the resultant high utilization of potassium gluconate medications. The increasing application of potassium gluconate in food additives is set to propel the growth of the Potassium Gluconate Market during the forecast period 2022-2027. This represents the Potassium Gluconate Industry Outlook.

Report Coverage

The report: Potassium Gluconate Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Potassium Gluconate Market.

By Product Type: Food Grade, Pharmaceutical Grade.
By End-User: Hospitals, Clinics, Others.
By Geography: North America (U.S, Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, the North American Potassium Gluconate Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the surging intake of dietary supplements including potassium gluconate, a salt of potassium cation in the North American region.
  • Potassium Gluconate Market growth is being driven by the burgeoning awareness regarding health involving intake of potassium gluconate, a salt of potassium cation, and the growing population of the elderly. However, the binding regulations for novel pharmaceutical products is one of the major factors hampering the growth of the Potassium Gluconate Market.
  • Potassium Gluconate Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Potassium Gluconate Market report

Potassium Gluconate Market Share, By Geography, 2021(%):

Potassium Gluconate Market

For more details on this report - Request for Sample

Potassium Gluconate Market Segment Analysis – By Product Type:

The Potassium Gluconate Market based on product type can be further segmented into Food Grade and Pharmaceutical Grade. The Food Grade Segment held the largest market share in 2021. This growth is owing to the surging application of food-grade potassium gluconate which is a salt of potassium cation as a food additive to maintain potassium levels in the diet. The advantages of potassium gluconate supplements like enhanced heart health, averting hypokalemia, better bone health, and improved muscle function are further propelling the growth of the food-grade segment.

Furthermore, the Pharmaceutical Grade is estimated to grow with the fastest CAGR of 4.9% during the forecast period 2022-2027 owing to the heightening utilization of potassium gluconate which is a salt of potassium cation as a potassium source against lack of potassium or as a systemic alkaliser.

Potassium Gluconate Market Segment Analysis – By End-User:

The Potassium Gluconate Market based on end-user can be further segmented into Hospitals, Clinics, and Others. The Hospitals segment held the largest market share in 2021. This growth is owing to the accelerated application of potassium gluconate which is a salt of potassium cation in treating increasing count of cases of hypokalemia in hospitals. The increased availability of hospitals, being open 24 hours a day and the enhanced facilities in private hospitals like staying in one’s own room with a spouse and various affordable grades of private care are further propelling the growth of this segment.

Furthermore, the Clinics segment is estimated to grow with the fastest CAGR of 5.1% during the forecast period 2022-2027 owing to the surging application of potassium gluconate which is a salt of potassium cation as a dietary supplement to avert reduced potassium in conjunction with added benefits of clinics like more reliable shifts, lesser holiday and weekend hours, and long-term relationships with patients with tinier practices having more of a community feel.

Potassium Gluconate Market Segment Analysis – By Geography:

The Potassium Gluconate Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Potassium Gluconate Market) held the largest share with 36% of the overall market in 2021. The growth of this region is owing to the increasing predominance of unprovoked hypokalemia amidst the African-American population in the region resulting in the greater application of potassium gluconate, a salt of potassium cation. As per the Centers for Disease Control And Prevention (CDC), unprovoked hypokalemia can result in hypertension and is related to various forms of acknowledged secondary hypertension and hypertension is more predominant among the African American population in comparison with European American population in the U.S. The expanding utilization of potassium gluconate worldwide as an active constituent in supplements and the soaring consumption of these supplements in the North American region is further propelling the growth of the Potassium Gluconate Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like surging consumption of dietary supplements like potassium gluconate which is a salt of potassium cation. The extensive utilization of potassium gluconate in bakery, personal-care and agrochemicals is further fuelling the progress of the Potassium Gluconate Market in the Asia-Pacific region.

Potassium Gluconate Market Drivers

Increased Application Of Potassium Gluconate In Treatment And Prevention Of Hypokalemia Is Projected To Drive The Growth Of Potassium Gluconate Market:

Potassium Gluconate is a salt of potassium cation. Potassium Gluconate is a potassium additive recorded in the treatment and prevention of hypokalemia. A lot of potassium may be lost by way of urine, sweat, or bowel movements. Insufficient potassium consumption and minimized magnesium levels may lead to hypokalemia. One technique of treating hypokalemia is building up potassium levels. A potassium-rich diet is typically suggested. Potassium supplements like potassium gluconate can be taken to treat or prevent this condition. The surging application of potassium gluconate for prevention or treatment of Hypokalemia is therefore fuelling the growth of the Potassium Gluconate Market during the forecast period 2022-2027.

Increased Application Of Potassium Gluconate As Food Additive Is Expected To Boost The Demand Of Potassium Gluconate:

Potassium gluconate is a salt of Potassium cation and is categorized as a food additive by the U.S. Food And Drug Administration (FDA). It is also utilized as a potassium supplement. Potassium is an indispensable nutrient. It is the amplest cation in the intracellular liquid, where it plays an essential role in keeping up cell function. In dietary additives, potassium is frequently available as potassium chloride, but multiple additional forms like potassium citrate, phosphate, aspartate, bicarbonate, and gluconate are also utilized. Potassium gluconate is thought to be more agreeable and non-acidifying than potassium chloride (KCl). Reduced consumption of potassium may bring about the hazard of sickness owing to the extensive role of potassium in the human body. Therefore potassium gluconate is increasingly utilized as a food additive to maintain an appropriate level of potassium in the diet. The proliferating application of potassium gluconate as a food additive is driving the growth of the Potassium Gluconate Market during the forecast period 2022-2027.

Potassium Gluconate Market Challenges

Restrictions On Usage Of Potassium Gluconate Is Challenging The Growth Of The Potassium Gluconate Market:

Potassium Gluconate, a salt of potassium cation should not be utilized if a potassium-sparing diuretic like amiloride, eplerenone, spironolactone, or triamterene is being taken. If there are soaring levels of potassium in the blood, then potassium gluconate should not be utilized. In case of heart ailments, irregular heartbeats, diabetes, trouble swallowing, a serious burn hurt, an ulcer or other issues with stomach or intestine, Addison’s disease, an allergic reaction, kidney ailment, or dehydration, the physician needs to be consulted on whether usage of potassium gluconate is safe or not. In case of overdose, emergency medical attention needs to be sought at once. While taking potassium gluconate, usage of other potassium supplements, salt substitutes, or reduced-sodium foods needs to be avoided unless prescribed by the physician. These issues are hampering the growth of the Potassium Gluconate Market.

Potassium Gluconate Industry Outlook

Novel product launches, mergers and acquisitions, agreements, collaborations, ongoing R&D activities, expansions, investments, and joint ventures are key strategies adopted by players in this market. Potassium Gluconate top 10 companies include:

  1. Corbion N.V.
  2. Jungbunzlauer Suisse AG
  3. Jost Chemical Co.
  4. GlaxoSmithKline plc
  5. Novartis AG
  6. Merck and Co., Inc.
  7. Abbott Laboratories
  8. Boehringer Ingelheim GmbH
  9. AstraZeneca plc
  10. F. Hoffmann-La Roche AG

Acquisitions/Product Launches:

  • In October 2021, Boehringer Ingelheim declared the introduction of its University of Medicine Excellence (UME). In an absolute expression of dedication to people development and financing in a continuous learning culture. The firm has officially introduced UME and assigned responsibility to the globally-recognized Harvard Medical School (HMS) to deliver its inaugural program, ‘Accelerate’. Boehringer Ingelheim will devote 3.4 million USD to the program till the completion of next year.
  • In October 2021, Rhineland-Palatinate Minister President Malu Dreyer was present as Boehringer Ingelheim launched a novel tablet production facility in Ingelheim. Commencing at once, the Solids Launch Factory will make all the novel medications of the firm launched in tablet form (solids). The facility will make use of about 75 workers.
  • In April 2020, GlaxoSmithKline plc declared that the US Food and Drug Administration (FDA) endorsed the firm’s supplemental New Drug Application (sNDA) for Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as a monotherapy maintenance treatment for women with progressive epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy, despite biomarker status. Until now, only 20% of women with ovarian cancer, those with a BRCA mutation (BRCAm), we're qualified to be treated with a PARP inhibitor as monotherapy in the first-line maintenance setting. Zejula is the only oral monotherapy accessible as first-line maintenance treatment for women despite BRCA mutational status, attending to a great unmet requirement in ovarian cancer.

Related Reports

Manganese Gluconate Market – Forecast (2021 - 2026)
Report Code: CMR 1000

Calcium Gluconate Market – Forecast (2021 - 2026)
Report Code: FBR 73354

For more Lifesciences and Healthcare related reports, please click here

1. Potassium Gluconate Market Overview
    1.1 Definitions and Scope
2. Potassium Gluconate Market - Executive Summary
3. Potassium Gluconate Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Potassium Gluconate Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Potassium Gluconate Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Potassium Gluconate Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Potassium Gluconate Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Potassium Gluconate Market - By Product Type (Market Size –$Million/$Billion) 
    8.1 Food Grade
    8.2 Pharmaceutical Grade
9. Potassium Gluconate Market - By End-User (Market Size –$Million/$Billion) 
    9.1 Hospitals
    9.2 Clinics
    9.3 Others
10. Potassium Gluconate Market- By Geography (Market Size -$Million/Billion)
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2 South America
        10.2.1 Brazil
        10.2.2 Argentina
        10.2.3 Chile
        10.2.4 Colombia
        10.2.5 Rest of South America
    10.3 Europe
        10.3.1 Germany
        10.3.2 France
        10.3.3 UK
        10.3.4 Italy
        10.3.5 Spain
        10.3.6 Russia
        10.3.7 Rest of Europe
    10.4 Asia-Pacific
        10.4.1 China
        10.4.2 Japan
        10.4.3 South Korea
        10.4.4 India
        10.4.5 Australia & New Zealand
        10.4.6 Rest of Asia-Pacific
    10.5 Rest Of The World
        10.5.1 Middle East
        10.5.2 Africa
11. Potassium Gluconate Market- Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs, and partnerships
12. Potassium Gluconate Market– Industry Competition Landscape (Premium)
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key Companies
        12.1.3 Market Share by Countries – Key Companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. Potassium Gluconate Market– Key Company List by Country Premium (Premium)
14. Potassium Gluconate Market- Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"

LIST OF TABLES

1.Global Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
1.1 Oral Market 2023-2030 ($M) - Global Industry Research
1.2 Parenteral Market 2023-2030 ($M) - Global Industry Research
2.Global Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
2.1 Hopitals Market 2023-2030 ($M) - Global Industry Research
2.2 Clinic Market 2023-2030 ($M) - Global Industry Research
3.Global Potassium Gluconate Market , By Dosage Form Market 2023-2030 (Volume/Units)
3.1 Oral Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Parenteral Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Potassium Gluconate Market , By End-User Market 2023-2030 (Volume/Units)
4.1 Hopitals Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
5.1 Oral Market 2023-2030 ($M) - Regional Industry Research
5.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
6.North America Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
6.1 Hopitals Market 2023-2030 ($M) - Regional Industry Research
6.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
7.South America Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
7.1 Oral Market 2023-2030 ($M) - Regional Industry Research
7.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
8.South America Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
8.1 Hopitals Market 2023-2030 ($M) - Regional Industry Research
8.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
9.Europe Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
9.1 Oral Market 2023-2030 ($M) - Regional Industry Research
9.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
10.Europe Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
10.1 Hopitals Market 2023-2030 ($M) - Regional Industry Research
10.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
11.APAC Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
11.1 Oral Market 2023-2030 ($M) - Regional Industry Research
11.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
12.APAC Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
12.1 Hopitals Market 2023-2030 ($M) - Regional Industry Research
12.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
13.MENA Potassium Gluconate Market , By Dosage Form Market 2023-2030 ($M)
13.1 Oral Market 2023-2030 ($M) - Regional Industry Research
13.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
14.MENA Potassium Gluconate Market , By End-User Market 2023-2030 ($M)
14.1 Hopitals Market 2023-2030 ($M) - Regional Industry Research
14.2 Clinic Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Potassium Gluconate Market Revenue, 2023-2030 ($M)
2.Canada Potassium Gluconate Market Revenue, 2023-2030 ($M)
3.Mexico Potassium Gluconate Market Revenue, 2023-2030 ($M)
4.Brazil Potassium Gluconate Market Revenue, 2023-2030 ($M)
5.Argentina Potassium Gluconate Market Revenue, 2023-2030 ($M)
6.Peru Potassium Gluconate Market Revenue, 2023-2030 ($M)
7.Colombia Potassium Gluconate Market Revenue, 2023-2030 ($M)
8.Chile Potassium Gluconate Market Revenue, 2023-2030 ($M)
9.Rest of South America Potassium Gluconate Market Revenue, 2023-2030 ($M)
10.UK Potassium Gluconate Market Revenue, 2023-2030 ($M)
11.Germany Potassium Gluconate Market Revenue, 2023-2030 ($M)
12.France Potassium Gluconate Market Revenue, 2023-2030 ($M)
13.Italy Potassium Gluconate Market Revenue, 2023-2030 ($M)
14.Spain Potassium Gluconate Market Revenue, 2023-2030 ($M)
15.Rest of Europe Potassium Gluconate Market Revenue, 2023-2030 ($M)
16.China Potassium Gluconate Market Revenue, 2023-2030 ($M)
17.India Potassium Gluconate Market Revenue, 2023-2030 ($M)
18.Japan Potassium Gluconate Market Revenue, 2023-2030 ($M)
19.South Korea Potassium Gluconate Market Revenue, 2023-2030 ($M)
20.South Africa Potassium Gluconate Market Revenue, 2023-2030 ($M)
21.North America Potassium Gluconate By Application
22.South America Potassium Gluconate By Application
23.Europe Potassium Gluconate By Application
24.APAC Potassium Gluconate By Application
25.MENA Potassium Gluconate By Application
26.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Boehringer Ingelheim Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Vectura Group Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Pifizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)